Skip to main content

and
  1. Article

    Open Access

    Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study

    The aim of this study was to evaluate feasibility and toxicity of escalating doses of epirubicin and paclitaxel plus fixed dose of etoposide and to define the activity of the triplet in extensive disease small...

    C Tibaldi, T Prochilo, F Russo, M C Pennucci, A Del Freo in British Journal of Cancer (2006)